Status:
NOT_YET_RECRUITING
Role of Plasma Rich Growth Factor in Repair Primary Cleft Palate
Lead Sponsor:
Cairo University
Conditions:
Cleft Palate
Plasma Rich in Growth Factors
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
Does the plasma-rich growth factor (PRGF) with primary cleft palate repair accelerate wound healing and prevent post-operative oronasal fistula occurrence?
Detailed Description
The primary objective is to assess and evaluate the improvement of wound healing (edema at 5th day post operatively) as a primary outcome, and secondary objective is to assess and evaluate the wound c...
Eligibility Criteria
Inclusion
- systemically healthy patients (American Society of Anesthesiologists -ASA I and II); not older than 6-18 months
- Patients with primary non-syndromic isolated cleft palate
- Apprehensive to be in the study.
Exclusion
- Patients with recurrent palatal fistula
- Existence of syndromic cleft palate
- Blood diseases and platelet disorders (hematological disease)
- Systematic disease radiotherapy or chemotherapy for malignancy
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06889181
Start Date
April 1 2025
End Date
June 30 2027
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry, Cairo University
Manial, Cairo Governorate, Egypt